{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:35:26Z","timestamp":1790969726893,"version":"4.1.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["JBMR Plus"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Stopping treatment for osteoporosis with denosumab (Dmab) leads to a major and rapid loss in bone mineral density (BMD) and a risk of vertebral fracture. Subsequent treatment with bisphosphonate (Bp) does not completely prevent this bone loss. We carried out a prospective pilot study to find out whether the gradual dose reduction with denosumab could prevent this bone loss. We proposed a therapeutic protocol consisting in reducing the doses of Dmab to women treated with Dmab for postmenopausal osteoporosis. Six months after the last dose of Dmab 60\u2009mg, the subsequent injection was performed with a reduced dose of 30\u2009mg, and the month\u201012 injection was a 15\u2010mg injection. BMD and serum C\u2010terminal telopeptide of type I collagen\u00a0(CTX) were measured at the start of treatment with Dmab (T0), at the last dose with 60\u2009mg (T1), and at 6\u2009months (T2) and 12\u2009months (T3) after the last 15\u2009mg Dmab injection. We included 13 patients aged 68.7\u2009\u00b1\u20093\u2009years, and treated with Dmab for 45.2\u2009\u00b1\u20095\u2009months. At the lumbar spine, 39% of the initial gain in BMD was preserved 1\u2009year after the last dose (15\u2009mg). Conversely, at the hip, the bone loss at the end of the treatment reduction protocol was equivalent to the initial gain. The mean CTX level was 166\u2009\u00b1\u2009152\u2009pg\/mL 6\u2009months after the last dose (T2; 15\u2009mg), and 549\u2009\u00b1\u2009425\u2009pg\/mL 12\u2009months after the last dose (T3; 15\u2009mg). One patient presented two vertebral fractures, 8\u2009months after the last dose of Dmab (15\u2009mg). Gradual dose reduction of denosumab (30\u2009mg then 15\u2009mg) does not prevent bone loss in the hip and partially maintains the initial gain at the spine. \u00a9 2023 The Authors.\n                    <jats:italic>JBMR Plus<\/jats:italic>\n                    published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.\n                  <\/jats:p>","DOI":"10.1002\/jbm4.10731","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T07:55:46Z","timestamp":1678262146000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Discontinuation of Denosumab: Gradual Decrease in Doses Preserves Half of the Bone Mineral Density Gain at the Lumbar Spine"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2319-6686","authenticated-orcid":false,"given":"Michel","family":"Laroche","sequence":"first","affiliation":[{"name":"Centre de Rhumatologie CHU Purpan \u2013 Universit\u00e9 Toulouse III  Toulouse cedex France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Couture","sequence":"additional","affiliation":[{"name":"Centre de Rhumatologie CHU Purpan \u2013 Universit\u00e9 Toulouse III  Toulouse cedex France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Degbo\u00e9","sequence":"additional","affiliation":[{"name":"Centre de Rhumatologie CHU Purpan \u2013 Universit\u00e9 Toulouse III  Toulouse cedex France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2008.04.007"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3110"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3337"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4098"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3962"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2020.100290"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-017-0288-x"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-019-00553-w"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3853"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044459"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbm4.10731","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbm4.10731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T09:58:03Z","timestamp":1710410283000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/7\/7\/n\/a\/7612280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1002\/jbm4.10731"],"URL":"https:\/\/doi.org\/10.1002\/jbm4.10731","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1002\/JBM4.10731\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBM4.10731\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBM4.10731\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBM4.10731\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBM4.10731\/v3\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBM4.10731\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBM4.10731\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBM4.10731\/v3\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBM4.10731\/v2\/decision1","asserted-by":"object"}]},"ISSN":["2473-4039","2473-4039"],"issn-type":[{"value":"2473-4039","type":"print"},{"value":"2473-4039","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]},"assertion":[{"value":"2022-06-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e10731"}}